Improved profit and divi at Bodycote
Heat treatment firm Bodycote posted an 8.7% rise in half year pre-tax profit and said its expects growth in aerospace, energy and new technologies to counteract negative economic headwinds.
Heat treatment firm Bodycote posted an 8.7% rise in half year pre-tax profit and said its expects growth in aerospace, energy and new technologies to counteract negative economic headwinds.
Profit before taxation rose to £43.8m for the six months ended 30 June 2012 from £40.3m before. Revenue rose to £301.3m during the period from £288.2m previously.
Operating profit increased to £45.6m from £42.7m while net debt fell to £16.7m from £33.7m.
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE

Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Chief executive Stephen Harris commented: "The group delivered a strong first half performance despite currency headwind and weakened demand in the Eurozone economies."
Looking forward into the second half, growth in aerospace and energy together with new technologies, is expected to counteract the effect of slowing economies, he added.
Bodycote has offered an interim dividend per share of 4p, up from 3.6p earlier.
CJ
Sign up for MoneyWeek's newsletters
Get the latest financial news, insights and expert analysis from our award-winning MoneyWeek team, to help you understand what really matters when it comes to your finances.
-
Trump wants to colonise Mars – will it happen?
Donald Trump wants to plant the US flag on Mars. Could humans really live there?
By Simon Wilson
-
Klarna postpones US IPO as Trump's tariffs rattle markets
Buy-now-pay-later lender Klarna has postponed its US initial public offering owing to the market turbulence. It is not alone, says Matthew Partridge
By Dr Matthew Partridge